The Food and Drug Administration (FDA) performed a cost and benefit analysis evaluating the economic impact of the final rule.
As per the FDA, a cost and benefit analysis was created and had influence over the final rule.
The FDA did not bother to conduct a cost and benefit analysis and as a result the final rule was not known to have any economic impact.
Similar to other taxes, they get categorized as generating nonexchange revenue.
There  is a sidewalk.
The swimmer is seen by the cameraman when he crossed the line.
The runner is tying her shoes.
A clown lies on a horse.
She stood glumly, stumped as ever.